CV
CapsoVision, Inc.
There isn't enough reported data to score CV yet.
CV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
CV's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CV PE Valuation
CV has no meaningful PE right now: it lost money over the past year.
CV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect CV's losses to shrink, with revenue growing.
CV Earnings Per Share
CV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.6M | +0.8% |
| Q2 2026 | $3.6M | +9.9% |
| Q1 2026 | $2.8M | +0.3% |
| Q4 2025 | $3.9M | +13% |
| Q3 2025 | $3.5M | +19% |
| Q2 2025 | $3.3M | +17% |
| Q1 2025 | $2.8M | +12% |
CV's revenue has grown year over year every quarter since early 2025: $4M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -207% | +20 points |
| Q2 2026 | -208% | -68 points |
| Q1 2026 | -254% | -61 points |
| Q4 2025 | -191% | -56 points |
| Q3 2025 | -227% | -31 points |
| Q2 2025 | -140% | +45 points |
| Q1 2025 | -193% | -25 points |
| Q4 2024 | -134% | N/A |
CV's operating margin was −207% last quarter, up 20 points from the same quarter a year ago.
CV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.1M | -$1.4M |
| Q1 2026 | -$6.1M | -$1.1M |
| Q4 2025 | -$7.7M | -$2.3M |
| Q3 2025 | -$5.7M | +$1.4M |
| Q1 2025 | -$5M | -$994K |
CV has burned cash in almost every quarter: −$29M over the past year, against −$23M the year before.
CV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +631K shares |
| 1 year | +9.1% | +4.2M shares |
CV has 51M diluted shares, up 9.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
CV Net Leverage
CV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.5 | Neutral |
| Stochastic | 46.5 | Neutral |
CV's weekly RSI is 48 (neutral) and its Stochastic is 47 (neutral).
CV PE vs Healthcare Sector
CV has no meaningful PE right now: it lost money over the past year.
CV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.54 | 4.1% below |
| 20 week MA | $6.51 | 3.7% below |
| 50 week MA | $6.87 | 8.7% below |
CV is in a downtrend: it's below all three of its weekly moving averages, and 8.7% below its 50-week average.
CV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $4.40 | $13.0 | +196% |
| 2026 YTD | $13.0 | $6.27 | -52% |
CV has finished every year since 2025 higher, and it's down 52% so far in 2026.